Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression Post author:Sam Post published:November 8, 2017 Post category:BioPharma The positive results support the company’s planned regulatory submissions. Source: BioSpace You Might Also Like Reverse Merger With Gives Cerulean Execs a Parting Gift—Bonuses March 21, 2017 Former Top Biotech Analyst Charged With Insider Trading September 26, 2017 Bay Area GRAIL's Billion Gamble on the Perfect Cancer Test June 5, 2017
